Lincoln Pharmaceuticals Limited has informed the Exchange about General Updates
LINCOLN · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Lincoln Pharmaceuticals has appointed M/s Ankit Sethi & Associates, a Peer Reviewed Practicing Company Secretaries firm, as its new Secretarial Auditor. The appointment is for an initial term of 5 consecutive years, from April 1, 2025 to March 31, 2030, and is subject to shareholder approval at the upcoming Annual General Meeting. The appointment was recommended by the Audit Committee and approved by the Board of Directors at a meeting held on August 7, 2025. Ankit Sethi & Associates has over 10 years of experience in listed company compliances, secretarial audits, due diligence, and corporate restructuring matters.
This is a routine regulatory compliance appointment required under the Companies Act, 2013 and SEBI Listing Regulations. It is unlikely to have any material impact on the stock price or shareholder value, as it is a standard governance requirement.